Modalis Therapeutics
Company

Modalis Therapeutics

Biotechnology Research Cambridge, Massachusetts, United States 22 employees
Employees
22
Contacts
4
Emails
4
Phones
2

Modalis Therapeutics Overview

Headquarters
Cambridge, Massachusetts, United States
Industry
Biotechnology Research
Employees
22
Founded
2016
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Modalis Therapeutics

Modalis Therapeutics Corporation (Tokyo Mothers 4883) is developing precision genetic medicines through epigenetic gene modulation. Modalis is advancing therapies for orphan genetic diseases using its proprietary CRISPR-GNDM technology which enables the locus specific modulation of gene expression or histone modification without the need for double- stranded DNA cleavage, gene editing or base editing. Modalis is headquartered in Tokyo with laboratories and R&D facilities in Cambridge,

Modalis Therapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Modalis Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Talha Akbulut Director at Modalis Therapeutics
Email Phone
Haru Morita Founder, President, and CEO at Modalis
Email
Yuanbo Qin Senior Director at Modalis Therapeutics
Email Phone
Alec Desimone Principal Scientist at Modalis
Email

Employees by Management Level

Director 2 profiles
Executive 1 profile
Senior / Lead 1 profile

Compare Similar Companies to Modalis Therapeutics